Jump to content

Bleselumab

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 18:50, 14 November 2019 (autocalc. (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Bleselumab
Monoclonal antibody
Type?
SourceHuman
TargetCD40
Clinical data
Other namesASKP1240
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC6412H9906N1690O2018S38
Molar mass144175.87 g·mol−1

Bleselumab (INN;[1] development code ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.

This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.[2]

References

  1. ^ World Health Organization (2015). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 113" (PDF). WHO Drug Information. 29 (2).
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Bleselumab, American Medical Association.
Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Bleselumab&oldid=926181891"